| Albert W. Brzeczko |
Albert W. Brzeczko is currently the Vice President-Pharmaceutical Sciences at Acura Pharmaceuticals, Inc. since 2019. He is also currently the Vice President-Technical Affairs at Acura Pharmaceutical Technologies, Inc. since 2009. Previously, he worked as the VP-Global Pharma New Product Development at International Specialty Products, Inc. from 1999 to 2009. Dr. Brzeczko obtained his undergraduate and doctorate degrees from the University of Maryland. |
| Robert A. Seiser |
Robert A. Seiser is currently the Chief Financial Officer & Senior Vice President at Acura Pharmaceuticals, Inc. He previously worked as the Treasurer & Controller at TC Manufacturing Co. from 1992 to 1998. He completed his undergraduate degree at Loyola University of Chicago. |
| Robert B. Jones |
Robert B. Jones is currently the President, Chief Executive Officer & Director at Acura Pharmaceuticals, Inc. He previously worked as the VP-Finance, Strategy & Business Analysis at Adolor Corp. from 2003 to 2008. He also held the position of Vice President-Marketing & Business Development at Endeavor Pharmaceuticals, Inc. and Vice President-Sales & Marketing at Purepac Pharmaceutical Co. Additionally, he served as the Chief Operating Officer & Vice President-Finance at Opt-e-scrip, Inc. from 2000 to 2003. Mr. Jones completed his undergraduate degree at Cornell University and holds an MBA from The University of North Carolina at Charlotte. |
| Bruce F. Toby Wesson |
Joined Galen in 1991 after serving as a Senior Vice President and Managing Director in the Corporate Finance Division at Smith Barney, where he worked for over 23 years. During his tenure at Smith Barney, Mr. Wesson directed the Major Account Group and was Senior Managing Director in charge of the East Coast region. Mr. Wesson was also Chairman of the Valuation and Opinion Committee for Corporate Finance. In this capacity, he was ultimately responsible for all of the valuation and opinions given by Smith Barney. Mr. Wesson currently serves on the Board of Directors of MedAssets (Vice Chairman), Derma Sciences, Acura Pharmaceuticals, and TPS. Mr. Wesson is a past trustee of Colgate University for nine years and had served as President of Colgate’s Alumni Corporation Board of Directors. He also serves as Chairman of the Board of the Overlook Hospital Foundation. He earned a B.A. from Colgate University and a M.B.A. from Columbia University’s Graduate School of Business. |
| William G. Skelly |
William G. Skelly is currently the Chairman, President & Chief Executive Officer at Central Biomedia, Inc. and SERA, Inc. He is also an Independent Director at Acura Pharmaceuticals, Inc. Previously, he served as the President of Martec Pharmaceutical, Inc. from 1985 to 1990. Skelly completed his undergraduate degree at Michigan State University and holds an MBA from the University of Missouri-Kansas City. |
| Immanuel Thangaraj |
Immanuel Thangaraj is the founder of Olympic Ophthalmics, Inc. (founded in 2017) and holds the title of Director. He currently holds the position of Independent Director at Acura Pharmaceuticals, Inc. (since 2002), Director at Proteus Digital Health, Inc. (since 2006), Director at TearScience, Inc., Managing Director at Essex Woodlands Management, Inc. (since 1996), President & Director at Clear Vascular, Inc., Director at Explorer Surgical Corp. (since 2019), and Director at Exubrion Therapeutics, Inc. Mr. Thangaraj has held former positions as Director at iKnowMed, Inc. (2000-2007), Director at Medlogics Device Corp., Director at MAP International, Inc., Director at Kona Medical, Inc., Director at PreCision Dermatology, Inc. (2010-2014), Director at CBR Systems, Inc., Director at Sound ID Corp., and Portfolio Manager at ARCH Venture Partners LLC. He obtained his undergraduate degree and MBA from The University of Chicago. |
| George K. Ross |
George K. Ross is an Independent Director at Acura Pharmaceuticals, Inc. He previously held positions as Chief Financial Officer, Director & Executive VP at Official Payments Holdings, Inc., Director & Senior Financial Officer at Axel Johnson, Inc., Executive Director-Foundations & Partnerships at World Vision, Inc., and Partner at Heartwood Partners, LLC. He also served as Chief Financial Officer & Executive Vice President at Aminoil USA, Inc. Ross holds an MBA from The Ohio State University and an undergraduate degree from Ohio Wesleyan University. |
